Patents by Inventor Michael J. Fazio

Michael J. Fazio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110092741
    Abstract: The present invention generally relates to a process for preparing a 1,2-ethylenediamine; 1,2-propylenediamine; or a mixture thereof by way of a catalyzed reductive amination reaction employing hydrogen, a reductive amination catalyst, (C3-C40)polyhydric alcohol having at least three hydroxy groups on consecutive carbon atoms thereof, and primary amine, the catalyzed reductive amination reaction employing reaction conditions that are effective for reductively aminating at least two of the hydroxy groups of the (C3-C40)polyhydric alcohol and reductively eliminating at least one other of the hydroxy groups of the (C3-C40)polyhydric alcohol in such a way so as to give a 1,2-ethylenediamine; 1,2-propylenediamine; or a mixture thereof.
    Type: Application
    Filed: August 5, 2010
    Publication date: April 21, 2011
    Inventors: Michael J. Fazio, Erich J. Molitor
  • Publication number: 20090221808
    Abstract: The invention is a process for the preparation of at least one nucleic acid duplex by the steps of: (a) synthesizing a first single strand oligonucleotide to produce a crude solution of the first single strand oligonucleotide; (b) purifying the first single strand oligonucleotide from the crude solution by first liquid chromatography to produce a solution of purified first single strand oligonucleotide in a first liquid chromatography eluant; (c) synthesizing a second single strand oligonucleotide to produce a crude solution of the second single strand oligonucleotide; (d) purifying the second single strand oligonucleotide from the crude solution by second liquid chromatography to produce a solution of purified second single strand oligonucleotide in a second liquid chromatography eluant; (e) mixing the solution of purified first single strand oligonucleotide in the first liquid chromatography eluant with the solution of purified second single strand oligonucleotide in the second liquid chromatography eluant
    Type: Application
    Filed: November 3, 2006
    Publication date: September 3, 2009
    Inventor: Michael J. Fazio
  • Patent number: 6312679
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: November 6, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Donald A. Kaplan, William J. Kruper, Jr., Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson
  • Patent number: 6177414
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: January 23, 2001
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, William J. Kruper, Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson, Donald A. Kaplan
  • Patent number: 6013251
    Abstract: The narrow poly- or mono-dispersed oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a recurring unit of from 3 to 50. These oligomers are water-soluble, preferably have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geometry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The narrow poly- or mono-dispersed oligomers are useful for the treatment and/or diagnosis of AIDS and/or ARC or HSV.
    Type: Grant
    Filed: April 1, 1997
    Date of Patent: January 11, 2000
    Assignees: The Dow Chemical Co., Merrell Pharmaceuticals Inc.
    Inventors: Alan D. Cardin, William A. Fordyce, Michael J. Mullins, Thomas A. Chamberlin, Michael J. Fazio
  • Patent number: 5986044
    Abstract: The narrow poly- or mono-dispersed oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a recurring unit of from 3 to 50. These oligomers are water-soluble, preferably have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geometry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The narrow poly- or mono-dispersed oligomers are useful for the treatment and/or diagnosis of AIDS and/or ARC or HSV.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: November 16, 1999
    Assignees: The Dow Chemical Co., Merrell Pharmaceuticals Inc.
    Inventors: Alan D. Cardin, Michael J. Mullins, William A. Fordyce, Thomas A. Chamberlin, Michael J. Fazio
  • Patent number: 5714166
    Abstract: Dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response modifier, have been prepared. The conjugate can also have a target director present, and when it is present then the carried material may be a bioactive agent. Preferred dendritic polymers are dense star polymers, which have been complexed with biological response modifiers. These conjugates and complexes have particularly advantageous properties due to their unique characteristics.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: February 3, 1998
    Assignees: The Dow Chemical Company, Dendritech Incorporated, The Regents of the University of Michigan
    Inventors: Donald A. Tomalia, James R. Baker, Roberta C. Cheng, Anna U. Bielinska, Michael J. Fazio, David M. Hedstrand, Jennifer A. Johnson, Donald A. Kaplan, deceased, Scott L. Klakamp, William J. Kruper, Jr., Jolanta Kukowska-Latallo, Bartley D. Maxon, Lars T. Piehler, Ian A. Tomlinson, Larry R. Wilson, Rui Yin, Herbert M. Brothers, II
  • Patent number: 5527524
    Abstract: Dense star polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: April 5, 1993
    Date of Patent: June 18, 1996
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Larry R. Wilson, David M. Hedstrand, Ian A. Tomlinson, Michael J. Fazio, William J. Kruper, Jr., Donald A. Kaplan, Roberta C. Cheng, David S. Edwards, Chu W. Jung
  • Patent number: 5512177
    Abstract: The narrow poly- or mono-dispersed oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a recurring unit of from 3 to 50. These oligomers are water-soluble, preferably have a rigid backbone, have recurring units coupled by carbonyl linking moities which have anionic groups, display predominantly linear geometry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The narrow poly- or mono-dispersed oligomers are useful for the treatment and/or diagnosis of AIDS and/or ARC or HSV.
    Type: Grant
    Filed: November 22, 1993
    Date of Patent: April 30, 1996
    Assignees: The Dow Chemical Co., Merrell Dow Pharmaceuticals Inc.
    Inventors: Alan D. Cardin, Michael J. Mullins, William A. Fordyce, Thomas A. Chamberlin, Michael J. Fazio
  • Patent number: 5424063
    Abstract: The narrow poly- or mono-dispersed oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a recurring unit of from 3 to 50. These oligomers are water-soluble, preferably have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geometry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The narrow poly- or mono-dispersed oligomers are useful for the treatment and/or diagnosis of AIDS and/or ARC or HSV.
    Type: Grant
    Filed: January 9, 1992
    Date of Patent: June 13, 1995
    Assignees: The Dow Chemical Company, Merrell Dow Pharmaceuticals, Inc.
    Inventors: Alan D. Cardin, William A. Fordyce, Michael J. Mullins, Thomas A. Chamberlin, Michael J. Fazio
  • Patent number: 5338532
    Abstract: Starburst conjugates which are composed of at least one dendrimer in association with at least one unit of a carried agricultural, pharmaceutical, or other material have been prepared. These conjugates have particularly advantageous properties due to the unique characteristics of the dendrimer.
    Type: Grant
    Filed: February 13, 1991
    Date of Patent: August 16, 1994
    Assignee: The Dow Chemical Company
    Inventors: Donald A. Tomalia, Donald A. Kaplan, William J. Kruper, Jr., Roberta C. Cheng, Ian A. Tomlinson, Michael J. Fazio, David M. Hedstrand, Larry R. Wilson
  • Patent number: 5284644
    Abstract: A group of functionalized polyamine chelants that form complexes with rhodium are disclosed. The rhodium complexes can be attached to an antibody or antibody fragment and used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 28, 1990
    Date of Patent: February 8, 1994
    Inventors: William J. Kruper, Jr., William A. Fordyce, Douglas K. Pollock, Michael J. Fazio, Muthiah N. Inbaskaran, Ramaiah Muthyala
  • Patent number: 5034536
    Abstract: Unsaturated esters with an alkyl group at the 2 carbon, such as methyl methacrylate, react with .beta.-aminoalkanols, such as 2-aminoethanol, in the presence of an alkali metal alkoxide or hydroxide such as sodium methoxide, under moderate temperatures to form an amide such as N-(2-hydroxyethyl)methacrylamide. The amide may be cyclized by a weak Lewis acid, such as ferric chloride, at about 220.degree. C. to form a 2-alkenyl oxazoline, such as isopropenyl oxazoline.
    Type: Grant
    Filed: June 22, 1990
    Date of Patent: July 23, 1991
    Assignee: The Dow Chemical Company
    Inventor: Michael J. Fazio
  • Patent number: 5006643
    Abstract: The present invention is directed to a novel process for preparing isothiocyanate functionalized chelates by reacting amino functionalized chelates with thiophosgene.
    Type: Grant
    Filed: July 20, 1989
    Date of Patent: April 9, 1991
    Assignee: The Dow Chemical Company
    Inventors: Michael J. Fazio, Douglas K. Pollock, Nicolas J. Kotite
  • Patent number: 5006567
    Abstract: Hydrazone compounds having two organic moieties joined by a hydrazone group, such as phenylacetone t-butyl hydrazone, are useful blowing agents for foaming polymers, such as bisphenol A/phosgene polycarbonate at temperatures above about 280.degree. C., and particularly at about 300.degree. C. to about 310.degree. C. Polycarbonate polymers formed using the hydrazones as foaming agents show a high impact strength.
    Type: Grant
    Filed: October 11, 1988
    Date of Patent: April 9, 1991
    Assignee: The Dow Chemical Company
    Inventors: Michael J. Fazio, Richard A. Wolf, Edwin J. Wilson, Susan Wollowitz
  • Patent number: 4994560
    Abstract: A group of functionalized polyamine chelants that form complexes with radioactive rhodium are disclosed. The rhodium complexes can be attached to an antibody or antibody fragment and used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: June 24, 1987
    Date of Patent: February 19, 1991
    Assignee: The Dow Chemical Company
    Inventors: William J. Kruper, Jr., Douglas K. Pollock, William A. Fordyce, Michael J. Fazio, Muthiah N. Inbasekaran
  • Patent number: 4826588
    Abstract: The separation of coal from pyrite during a froth flotation process is enhanced by the use of an effective amount of a pyrite depressant. The depressant is a hydrophilic nitrogen-sulfur-containing compound.
    Type: Grant
    Filed: April 28, 1988
    Date of Patent: May 2, 1989
    Assignee: The Dow Chemical Company
    Inventors: Richard R. Klimpel, Robert D. Hansen, Michael J. Fazio
  • Patent number: 4661633
    Abstract: The specification discloses a method for preparing quaternary ammonium salts by reacting a tertiary amine salt with a 2-oxazoline or 2-oxazine compound.
    Type: Grant
    Filed: November 15, 1985
    Date of Patent: April 28, 1987
    Assignee: The Dow Chemical Company
    Inventor: Michael J. Fazio
  • Patent number: 4595704
    Abstract: Partially neutralize a strong-acid cation-exchange resin in acid form using an N-(2-mercaptoalkyl)amide in the presence of water.
    Type: Grant
    Filed: August 13, 1984
    Date of Patent: June 17, 1986
    Assignee: The Dow Chemical Company
    Inventor: Michael J. Fazio
  • Patent number: 4539416
    Abstract: A process for making N-furfurylthioalkyl carboxamide by reacting an oxaz(ol)ine with furfurylmercaptan in the absence of a transition metal catalyst. The carboxamide may then be hydrolyzed to form the 2-furfurylthioalkylamine.
    Type: Grant
    Filed: June 10, 1983
    Date of Patent: September 3, 1985
    Assignee: The Dow Chemical Company
    Inventors: Harold G. Fravel, Jr., Michael J. Fazio